The NIS-2 Directive tightens cybersecurity requirements across the EU and presents new challenges, particularly for MedTech companies. Connected products, complex supply chains, and increasing regulatory demands are intensifying the pressure to manage cyber risks holistically and further develop internal security organizations. 

This white paper examines the impact of the new requirements on MedTech companies and highlights the key challenges that arise. It demonstrates how structured, risk-based approach can help organizations implement these requirements efficiently. At the same time, it enables companies to strategically enhance their cybersecurity organizations to meet regulatory obligations and strengthen long-term resilience.